Dr. Eric Jen, PharmD, is the publications strategy lead at Neurocrine Biosciences, Inc., overseeing both in-line and pipeline products across the portfolio. He has more than 10 years of experience in medical affairs and has published articles regarding the central nervous system, cardiovascular system, endocrinology, oncology, and immunology. Dr. Jen received his PharmD from Rutgers University, and is committed to building pathways of communication across health care communities.